MSK Fulton Market Phase 1
Chicago, US · Founded 2015 · Delaware LLC
Find your way into MSK Fulton Market Phase 1
Sign up to see every warm intro you have to MSK Fulton Market Phase 1
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MSK Fulton Market Phase 1 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MD
Matthew D. MeansManager
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 round · 2016
▶$1.3MraisedJan 2017 · 9 investors · ConstructionRule 506(b)
▶$1.3MraisedJan 2017 · 9 investors · Construction
Rule 506(b)Officers, directors & promoters on the filing
- Matthew D. MeansExecutive Officer, Director, Promoter
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- Minimum investment
- $10K
- Proceeds to insiders
- $129K
- First sale
- Oct 2016
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has MSK Fulton Market Phase 1 raised?
- MSK Fulton Market Phase 1 has disclosed $1.3M raised across 1 round.
- Where is MSK Fulton Market Phase 1 headquartered?
- MSK Fulton Market Phase 1 is headquartered in Chicago, US.